South Korea · Delayed Price · Currency is KRW T Scientific Statistics
Total Valuation
T Scientific has a market cap or net worth of KRW 31.63 billion. The enterprise value is 27.55 billion.
| Market Cap | 31.63B |
| Enterprise Value | 27.55B |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
T Scientific has 14.25 million shares outstanding. The number of shares has decreased by -49.12% in one year.
| Current Share Class | 14.25M |
| Shares Outstanding | 14.25M |
| Shares Change (YoY) | -49.12% |
| Shares Change (QoQ) | +400.00% |
| Owned by Insiders (%) | 0.33% |
| Owned by Institutions (%) | 0.03% |
| Float | 9.55M |
Valuation Ratios
The trailing PE ratio is 26.80.
| PE Ratio | 26.80 |
| Forward PE | n/a |
| PS Ratio | 0.89 |
| PB Ratio | 0.19 |
| P/TBV Ratio | 0.19 |
| P/FCF Ratio | 217.71 |
| P/OCF Ratio | 128.61 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 27.14, with an EV/FCF ratio of 189.59.
| EV / Earnings | 23.18 |
| EV / Sales | 0.78 |
| EV / EBITDA | 27.14 |
| EV / EBIT | 261.09 |
| EV / FCF | 189.59 |
Financial Position
The company has a current ratio of 2.24, with a Debt / Equity ratio of 0.04.
| Current Ratio | 2.24 |
| Quick Ratio | 1.80 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 6.62 |
| Debt / FCF | 46.22 |
| Interest Coverage | 0.12 |
Financial Efficiency
Return on equity (ROE) is 0.58% and return on invested capital (ROIC) is 0.06%.
| Return on Equity (ROE) | 0.58% |
| Return on Assets (ROA) | 0.04% |
| Return on Invested Capital (ROIC) | 0.06% |
| Return on Capital Employed (ROCE) | 0.06% |
| Weighted Average Cost of Capital (WACC) | 4.08% |
| Revenue Per Employee | 158.44M |
| Profits Per Employee | 5.30M |
| Employee Count | 224 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 43.42 |
Taxes
| Income Tax | -3.25B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.98% in the last 52 weeks. The beta is -0.28, so T Scientific's price volatility has been lower than the market average.
| Beta (5Y) | -0.28 |
| 52-Week Price Change | -60.98% |
| 50-Day Moving Average | 2,682.40 |
| 200-Day Moving Average | 4,236.03 |
| Relative Strength Index (RSI) | 40.15 |
| Average Volume (20 Days) | 49,870 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, T Scientific had revenue of KRW 35.49 billion and earned 1.19 billion in profits. Earnings per share was 82.84.
| Revenue | 35.49B |
| Gross Profit | 10.43B |
| Operating Income | 105.51M |
| Pretax Income | -2.35B |
| Net Income | 1.19B |
| EBITDA | 1.01B |
| EBIT | 105.51M |
| Earnings Per Share (EPS) | 82.84 |
Balance Sheet
The company has 10.70 billion in cash and 6.72 billion in debt, with a net cash position of 3.98 billion or 279.28 per share.
| Cash & Cash Equivalents | 10.70B |
| Total Debt | 6.72B |
| Net Cash | 3.98B |
| Net Cash Per Share | 279.28 |
| Equity (Book Value) | 169.20B |
| Book Value Per Share | 2,376.32 |
| Working Capital | 13.09B |
Cash Flow
In the last 12 months, operating cash flow was 245.96 million and capital expenditures -100.66 million, giving a free cash flow of 145.30 million.
| Operating Cash Flow | 245.96M |
| Capital Expenditures | -100.66M |
| Depreciation & Amortization | 909.35M |
| Net Borrowing | -4.79B |
| Free Cash Flow | 145.30M |
| FCF Per Share | 10.20 |
Margins
Gross margin is 29.38%, with operating and profit margins of 0.30% and 3.35%.
| Gross Margin | 29.38% |
| Operating Margin | 0.30% |
| Pretax Margin | -6.62% |
| Profit Margin | 3.35% |
| EBITDA Margin | 2.86% |
| EBIT Margin | 0.30% |
| FCF Margin | 0.41% |
Dividends & Yields
T Scientific does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 49.12% |
| Shareholder Yield | 49.12% |
| Earnings Yield | 3.76% |
| FCF Yield | 0.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 10, 2026. It was a reverse split with a ratio of 0.2.
| Last Split Date | Apr 10, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
T Scientific has an Altman Z-Score of 1.26 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.26 |
| Piotroski F-Score | 5 |